Eton Pharmaceuticals ETON Stock
Eton Pharmaceuticals Price Chart
Eton Pharmaceuticals ETON Financial and Trading Overview
| Eton Pharmaceuticals stock price | 38.5 USD |
| Previous Close | 36.61 USD |
| Open | 36.16 USD |
| Bid | 26.51 USD x 200 |
| Ask | 45.13 USD x 200 |
| Day's Range | 35 - 37.5 USD |
| 52 Week Range | 13.76 - 38.62 USD |
| Volume | 248.67K USD |
| Avg. Volume | 407.36K USD |
| Market Cap | 1.02B USD |
| Beta (5Y Monthly) | 0.861 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.06 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 45.67 USD |
ETON Valuation Measures
| Enterprise Value | 1.03B USD |
| Trailing P/E | N/A |
| Forward P/E | 19.861702 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 11.7656 |
| Price/Book (mrq) | 33.36908 |
| Enterprise Value/Revenue | 11.899 |
| Enterprise Value/EBITDA | 93.318 |
Trading Information
Eton Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.861 |
| 52-Week Change | 151.78% |
| S&P500 52-Week Change | 20.84% |
| 52 Week High | 38.62 USD |
| 52 Week Low | 13.76 USD |
| 50-Day Moving Average | 32.04 USD |
| 200-Day Moving Average | 21.98 USD |
ETON Share Statistics
| Avg. Volume (3 month) | 407.36K USD |
| Avg. Daily Volume (10-Days) | 485.42K USD |
| Shares Outstanding | 27.39M |
| Float | 21.26M |
| Short Ratio | 3.48 |
| % Held by Insiders | 4.44% |
| % Held by Institutions | 65.94% |
| Shares Short | 1.45M |
| Short % of Float | 7.43% |
| Short % of Shares Outstanding | 5.29% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -1.69% |
| Operating Margin (ttm) | 11.39% |
| Gross Margin | 59.71% |
| EBITDA Margin | 12.75% |
Management Effectiveness
| Return on Assets (ttm) | 4.76% |
| Return on Equity (ttm) | -5.35% |
Income Statement
| Revenue (ttm) | 86.93M USD |
| Revenue Per Share (ttm) | 3.22 USD |
| Quarterly Revenue Growth (yoy) | 40.40% |
| Gross Profit (ttm) | 51.92M USD |
| EBITDA | 11.09M USD |
| Net Income Avi to Common (ttm) | -1475000 USD |
| Diluted EPS (ttm) | -0.06 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 19.66M USD |
| Total Cash Per Share (mrq) | 0.72 USD |
| Total Debt (mrq) | 31.26M USD |
| Total Debt/Equity (mrq) | 102.11 USD |
| Current Ratio (mrq) | 1.205 |
| Book Value Per Share (mrq) | 1.119 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 15.84M USD |
| Levered Free Cash Flow (ttm) | 2.44M USD |
Profile of Eton Pharmaceuticals
| Country | United States |
| State | IL |
| City | Deer Park |
| Address | 21925 W. Field Parkway |
| ZIP | 60010-7278 |
| Phone | 847 787 7361 |
| Website | https://www.etonpharma.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 44 |
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Q&A For Eton Pharmaceuticals Stock
What is a current ETON stock price?
Eton Pharmaceuticals ETON stock price today per share is 38.5 USD.
How to purchase Eton Pharmaceuticals stock?
You can buy ETON shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Eton Pharmaceuticals?
The stock symbol or ticker of Eton Pharmaceuticals is ETON.
Which industry does the Eton Pharmaceuticals company belong to?
The Eton Pharmaceuticals industry is Drug Manufacturers - Specialty & Generic.
How many shares does Eton Pharmaceuticals have in circulation?
The max supply of Eton Pharmaceuticals shares is 27.39M.
What is Eton Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Eton Pharmaceuticals PE Ratio is now.
What was Eton Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Eton Pharmaceuticals EPS is -0.06 USD over the trailing 12 months.
Which sector does the Eton Pharmaceuticals company belong to?
The Eton Pharmaceuticals sector is Healthcare.
Eton Pharmaceuticals ETON included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26269.23 USD — |
+0.62
|
6.25B USD — | 26041.13 USD — | 26316.81 USD — | — - | 6.25B USD — |
|
US Tech Global Market Composite
NQGM
US
|
2296.71 USD — |
-0.17
|
— — | 2271.37 USD — | 2311.92 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1251.97 USD — |
+0.86
|
— — | 1233.72 USD — | 1252.49 USD — | — - | — — |
- {{ link.label }} {{link}}